Early access to sickle cell and thalassaemia screening and the early offer of prenatal diagnosis (PND) is important in giving women and couples time to consider their options.
We’re pleased to announce the publication of an updated version of the antenatal laboratory handbook for the NHS Sickle Cell and Thalassaemia (SCT) Screening Programme.
We have recently updated and published a one page summary for healthcare professionals explaining which newborn screening tests can be offered at different ages if any of these were initially missed.
As part of a wider investigation into why women are tested late, we commissioned the UK Thalassaemia Society (UKTS) and Sickle Cell Society (SCS) to carry out face to face interviews with women and couples who had recent experience of the SCT programme.
I’m the Sickle Cell and Thalassaemia Screening Lead at Northampton General Hospital and Kettering General Hospital. For the past year I’ve been on secondment as national project lead for the NHS Sickle Cell and Thalassaemia (SCT) Screening Programme.
Today is World Hepatitis Day, which makes it the right time to highlight the work of the NHS Infectious Diseases in Pregnancy Screening (IDPS) Programme on hepatitis B.
We’ve updated our antenatal and newborn screening information for public and professionals following a change to the vaccination schedule for babies.
Back in November 2016 and March 2017 we published blog articles about the additional option of non-invasive prenatal testing (NIPT) to the fetal anomaly screening pathway.
We have published new information that describes the checks and audits that are needed for the sickle cell and thalassaemia (SCT) screening pathway.
If you work in ultrasound or radiology you will be well aware there’s a national shortage of trained staff. Many ultrasound departments rely on agency sonographers.